For example, a variety of options have showed efficiency for treating BED, including antidepressants, anticonvulsants, opioid receptor antagonists, and anti-obesity medicines, such as cannabinoid receptor 1 (CB1) antagonists and GLP-1 analogs [44]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.